|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
52897829
Online Users :
461
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"lin c c"
Showing items 56-65 of 2549 (255 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C.; Yeh K.-H.; Yang C.-H.; CHIUN HSU; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:08Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:07Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Ni Y.-H.; Lin C.-L.; Hsu Y.-C.; Hsu C.-W.; Wu C.-Y.; Wu J.-C.; Cheng J.C.-H.; Leung S.W.; Chen S.-W.; Hsu H.-C.; Hong J.-H.; Wang P.-M.; Wang P.-M.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; CHIUN HSU; Chao Y.; Chen L.-T.; Lee P.-H.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Hung C.-F.; Huang S.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N. |
| 臺大學術典藏 |
2022-08-19T00:20:31Z |
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study
|
Lin C.-C.; Yang T.-S.; Yen C.-J.; Cheng R.; Liu J.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-12T08:07:48Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee S.-H.; Lin C.-C.; Wei C.-H.; Chang K.-P.; CHANG-TSU YUAN; Tsai C.-H.; Liu J.-H.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-08-12T08:07:47Z |
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
|
Chen T.-C.; Yao C.-Y.; Chen Y.-R.; CHANG-TSU YUAN; Lin C.-C.; Hsu Y.-C.; Chuang P.-H.; Kao C.-J.; Li Y.-H.; Hou H.-A.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-08-12T06:27:47Z |
Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker
|
Tseng C.-W.; Yang J.-C.; Chen C.-N.; Huang H.-C.; Chuang K.-N.; Lin C.-C.; Lai H.-S.; Lee P.-H.; KING-JEN CHANG; Juan H.-F. |
| 臺大學術典藏 |
2022-08-12T06:27:32Z |
Classification of benign and malignant breast tumors in ultrasound images with posterior acoustic shadowing using half-contour features
|
Zhou Z.; Wu S.; KING-JEN CHANG; Chen W.-R.; Chen Y.-S.; Kuo W.-H.; Lin C.-C.; Tsui P.-H. |
Showing items 56-65 of 2549 (255 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
